Dimensional Fund Advisors’s AC Immune ACIU Stock Holding History

Dimensional Fund Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$812K	Sell	340,082 -50,083	-13%	-$138K	﹤0.01%	2902
2026 Q1	$1.07M	Buy	390,165 +176,701	+83%	+$549K	﹤0.01%	2828
2025 Q4	$670K	Buy	213,464 +36,353	+21%	+$115K	﹤0.01%	2925
2025 Q3	$513K	Sell	177,111 -21,575	-11%	-$48.7K	﹤0.01%	2988
2025 Q2	$403K	Sell	198,686 -38,872	-16%	-$67.6K	﹤0.01%	3025
2025 Q1	$445K	Buy	237,558 +106,148	+81%	+$267K	﹤0.01%	3018
2024 Q4	$355K	Buy	131,410 +74,358	+130%	+$232K	﹤0.01%	3084
2024 Q3	$216K	Sell	57,052 -3,146	-5%	-$11K	﹤0.01%	3158
2024 Q2	$240K	Buy	60,198 +446	+0.7%	+$1.48K	﹤0.01%	3139
2024 Q1	$177K	Hold	59,752	–	–	﹤0.01%	3200
2023 Q4	$299K	Hold	59,752	–	–	﹤0.01%	3136
2023 Q3	$170K	Sell	59,752 -1,200	-2%	-$3.65K	﹤0.01%	3239
2023 Q2	$180K	Buy	60,952 +14,705	+32%	+$32.1K	﹤0.01%	3254
2023 Q1	$108K	Buy	+46,247	New	+$107K	﹤0.01%	3291
2022 Q3	–	Sell	-12,707	Closed	-$45K	–	3487
2022 Q2	$45K	Hold	12,707	–	–	﹤0.01%	3397
2022 Q1	$51K	Hold	12,707	–	–	﹤0.01%	3460
2021 Q4	$63K	Hold	12,707	–	–	﹤0.01%	3470
2021 Q3	$85K	Hold	12,707	–	–	﹤0.01%	3444
2021 Q2	$101K	Hold	12,707	–	–	﹤0.01%	3407
2021 Q1	$97K	Hold	12,707	–	–	﹤0.01%	3354
2020 Q4	$66K	Hold	12,707	–	–	﹤0.01%	3303
2020 Q3	$62K	Hold	12,707	–	–	﹤0.01%	3292
2020 Q2	$86K	Buy	12,707 +1,415	+13%	+$10.3K	﹤0.01%	3287
2020 Q1	$78K	Buy	+11,292	New	+$88.3K	﹤0.01%	3292

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dimensional Fund Advisors's ACIU Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its AC Immune (ACIU) stake by 13% in Q2 2026, selling an estimated $138K and leaving 340,082 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Dimensional Fund Advisors first reported a position in ACIU in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.07M in Q1 2026. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

Dimensional Fund Advisors held 340,082 shares of AC Immune worth $812K as of Q2 2026.
Dimensional Fund Advisors sold 50,083 AC Immune shares in Q2 2026, an estimated $138K.
AC Immune made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2902 holding.
Dimensional Fund Advisors first reported a position in AC Immune in Q1 2020 and has held it in 24 quarters since.
Dimensional Fund Advisors's AC Immune position peaked at $1.07M in Q1 2026.
43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.